These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 13180879)

  • 1. Heparin rebound; a clinical and experimental study.
    CATE WR; SADLER RN; SEITZMAN DM; LIGHT RA
    Am Surg; 1954 Aug; 20(8):813-9. PubMed ID: 13180879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the effect of strophanthin on blood coagulation with the aid of heparin test].
    ZAIDLER IaI
    Farmakol Toksikol; 1958; 21(4):42-6. PubMed ID: 13574231
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heparin treatment of hypertension; the effect of small repeated heparin injections on blood coagulation].
    KELLER R
    Medizinische; 1955 Apr; 14():492-5. PubMed ID: 14383075
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental studies on percutaneous efficacy of anticoagulative substances; potentiation of intravenously administered heparin by percutaneous hirudoid].
    PICHOTKA J; MAYER K
    Arzneimittelforschung; 1954 Apr; 4(4):277-82. PubMed ID: 13159729
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of taurolidine on experimental thrombus formation.
    Kaptanoglu L; Kucuk HF; Colak E; Kurt N; Bingul SM; Akyol H; Torlak OA; Yazici F
    Eur J Pharmacol; 2008 Jan; 578(2-3):238-41. PubMed ID: 17961549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does injection of a substituted butylamine, a histamine-liberator, cause release of heparin in dogs?].
    BINET L; QUIVY D
    C R Seances Soc Biol Fil; 1956; 150(12):2157-60. PubMed ID: 13437550
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of intramuscular administration of heparin in anticoagulant therapy].
    BROUSTET ; POUQUET ; BRICAUD
    J Med Bord; 1954 Apr; 131(4):371-5. PubMed ID: 13184258
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin release is insufficient in syringes with platelets as heparin source.
    Gruber M; Spaeth R; Bechmann V
    Clin Chim Acta; 2008 Sep; 395(1-2):187. PubMed ID: 18515082
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of cardiotonic glycosides on blood coagulation and heparin sensitivity].
    CALTABIANO S; CAVALLINI L; CAGIANELLI MA
    G Clin Med; 1958 Sep; 39(9):1377-95. PubMed ID: 13610006
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on the influence of reptilase on blood coagulation].
    HOHNEN HW
    Z Gesamte Exp Med; 1957; 128(4):427-36. PubMed ID: 13456688
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lysozyme in epistaxis: its action on coagulation factors, bacterial flora and cicatrization processes: clinical and experimental study].
    MAFFEI G; MIANI P
    Boll Mal Orecch Gola Naso; 1958; 76(5):512-56. PubMed ID: 13607665
    [No Abstract]   [Full Text] [Related]  

  • 14. Lysozyme and blood coagulation. I. Experimental study of the mechanism of coagulating action of lysozyme.
    PERUGINI S; GOBBI F; GHISLERI G
    Haematologica; 1957; 42(7):831-54. PubMed ID: 13474481
    [No Abstract]   [Full Text] [Related]  

  • 15. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulant action of organic arsenicals: liberation of heparin by neoarsphenamine; preliminary study].
    LIMONGI JP
    Arq Cir Clin Exp; 1953; 15(6):285-95. PubMed ID: 13125989
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anticoagulation and sepsis: the opportunity for a new use of heparin?].
    Jaimes F; de la Rosa G
    Biomedica; 2006 Mar; 26(1):150-60. PubMed ID: 16929913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ACTH-heparin regulation system on coagulation processes].
    BELLER FK
    Arztl Forsch; 1954 Jun; 8(6):I/243-9. PubMed ID: 13171198
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antagonistic effects of heparin during the second phase of coagulation].
    BURSTEIN M
    Sem Hop; 1954 Aug 26-30; 30(52-53):3051-4. PubMed ID: 13195759
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of line flush heparin contamination on thromboelastograph trace analysis.
    Schulte A; Clark M
    Anaesthesia; 2008 Dec; 63(12):1381-2. PubMed ID: 19032319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.